Related Experiment Video
Updated: Jul 3, 2026

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Published on: September 27, 2024
Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes
Jason Levi Esses1, Jonathan Rosman, Lien Thanh Do
1Department of Cardiology, Beth Israel Medical Center, 1st Ave. at 16th Street, Baird Hall, 5th Floor, New York, NY, 10003, USA.
Abstract:
A 56-year-old-man presented with syncope and torsades de pointes secondary to methadone-induced QT prolongation. After transition from methadone to buprenorphine, a partial mu-opiate-receptor agonist and a kappa-opiate-receptor antagonist, the QT normalized and ventricular arrhythmias resolved. Buprenorphine should be used for opiate dependence and chronic pain in patients with methadone-induced QT prolongation and as first line therapy in patients with risk factors for torsades de pointes.
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Oral Drug Delivery Systems: Continuous-Release Systems
IV Infusion to Oral Dosing: Conversion Methods
Depolarizing Blockers: Pharmocokinetics
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Drug Therapy
Antianxiety Medications

